Skip to main content

Peer Review reports

From: FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

Original Submission
28 Feb 2020 Submitted Original manuscript
16 Apr 2020 Reviewed Reviewer Report - Riaz Qureshi
10 May 2020 Author responded Author comments - Alexandra Poinas
Resubmission - Version 2
10 May 2020 Submitted Manuscript version 2
17 May 2020 Reviewed Reviewer Report - Riaz Qureshi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
19 May 2020 Editorially accepted
25 Jun 2020 Article published 10.1186/s13063-020-04432-w

You can find further information about peer review here.

Back to article page